Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

NCT03834766 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: AMPH ER Tab 5, 10, 15 and 20 mg
DRUG: AMPH ER Tab Matching Placebo 5, 10, 15 and 20 mg

Sponsor

Tris Pharma, Inc.

Collaborators

[object Object]